HTR1B and myeloproliferative neoplasm: The results obtained indicated that MPN patients who had at least one major thrombotic episode and/or signs of impaired microcirculation showed significantly increased HTR1B expression in PBMC compared to non‐thrombotic MPNs, non‐MPN thrombotic cases and normal subjects.